jbrown33	10.1016/j.pharmthera.2016.12.001	<http://dx.doi.org/10.1016/j.pharmthera.2016.12.001>; rel="canonical", <https://api.elsevier.com/content/article/PII:S0163725816302443?httpAccept=text/xml>; version="vor"; type="text/xml"; rel="item", <https://api.elsevier.com/content/article/PII:S0163725816302443?httpAccept=text/plain>; version="vor"; type="text/plain"; rel="item", <https://www.elsevier.com/tdm/userlicense/1.0/>; version="tdm"; rel="license", <http://creativecommons.org/licenses/by/4.0/>; version="vor"; rel="license"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.pharmthera.2016.12.001"><j.0:identifier>10.1016/j.pharmthera.2016.12.001</j.0:identifier><j.1:doi>10.1016/j.pharmthera.2016.12.001</j.1:doi><j.1:endingPage>115</j.1:endingPage><j.2:pageEnd>115</j.2:pageEnd><j.2:volume>172</j.2:volume><j.1:volume>172</j.1:volume><j.1:startingPage>101</j.1:startingPage><j.0:publisher>Elsevier BV</j.0:publisher><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2017-04</j.0:date><j.2:doi>10.1016/j.pharmthera.2016.12.001</j.2:doi><j.2:pageStart>101</j.2:pageStart><j.0:title>Maximising the potential of AKT inhibitors as anti-cancer treatments</j.0:title><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0163-7258"><owl:sameAs>urn:issn:0163-7258</owl:sameAs><j.0:title>Pharmacology &amp; Therapeutics</j.0:title><j.1:issn>0163-7258</j.1:issn><j.2:issn>0163-7258</j.2:issn></j.2:Journal></j.0:isPartOf><owl:sameAs rdf:resource="doi:10.1016/j.pharmthera.2016.12.001"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/udai-banerji-9c1q59e384u"><j.3:name>Udai Banerji</j.3:name><j.3:familyName>Banerji</j.3:familyName><j.3:givenName>Udai</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jessica-s-brown-9c1q59e384u"><j.3:name>Jessica S. Brown</j.3:name><j.3:familyName>Brown</j.3:familyName><j.3:givenName>Jessica S.</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.1016/j.pharmthera.2016.12.001"/></rdf:Description></rdf:RDF>
